Quarterly Report provides a comprehensive update on the state of play in their exploration during 2020 up to the end of September. Still have $5m in cash. Staff, Admin & Corp costs around $0.2M for qrt => approx. $1.2M per annum. Commentary seems measured but positive.
Still waiting on some drilling and DHEM survey results. Some info on next steps for Perrinvale Project but not a lot of detail or timings provided - would prefer CBE to be more specific in this area. Planning to do early exploration work on their Sandiman Project - good to read. Further news flow expected on their Botswana KLM opportunity before Christmas / within the next 2 months.
Good to finally get some news from the company. Going to be slow progress. At 14c their market cap is around $15M with $5M cash and an EV around $10M. If KLM drill results show good results over the coming month and CBE exercises their opt-in, then I would expect the share price to respond very positively.
Not investment advice. DYOR.
- Forums
- ASX - By Stock
- CBE
- CBE - Charts & Price Action
CBE
cobre limited
Add to My Watchlist
4.65%
!
4.5¢

CBE - Charts & Price Action, page-34
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.5¢ |
Change
0.002(4.65%) |
Mkt cap ! $19.95M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.5¢ | $4.498K | 99.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 123255 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 20037 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 123255 | 0.043 |
1 | 16728 | 0.042 |
2 | 33633 | 0.041 |
3 | 433400 | 0.040 |
1 | 78900 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 10037 | 2 |
0.046 | 50000 | 1 |
0.048 | 79821 | 1 |
0.050 | 100880 | 1 |
0.051 | 293902 | 2 |
Last trade - 15.38pm 27/06/2025 (20 minute delay) ? |
Featured News
CBE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online